ABVC BioPharma, Inc. (ABVC) vs BRIACELL THERAP (BCTX)

ABVC BioPharma, Inc. and BRIACELL THERAP are both Biotechnology companies. ABVC BioPharma, Inc. and BRIACELL THERAP are of similar size ($37.2M and $34.0M). ABVC BioPharma, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. Across the 10 metrics below, ABVC BioPharma, Inc. leads on 7 and BRIACELL THERAP on 3.

Valuation

Metric ABVC BCTX Biotechnology median
P/E n/m 1.94 7.88
P/S 22.77 n/m 11.47
P/B 2.42 1.34 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 24.03 n/m 10.73
Earnings yield (29.79%) 51.65% (28.84%)
Free cash flow yield (9.14%) (100.28%) (23.03%)

Profitability

Metric ABVC BCTX Biotechnology median
Gross margin 99.97% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) (173.55%) (57.72%)
Return on assets (39.88%) (139.20%) (49.22%)
Return on invested capital (33.45%) (3,311.00%) 0.00%

Growth

Metric ABVC BCTX Biotechnology median
Revenue growth (TTM) 5,035.43% — 5.64%
EPS growth (last fiscal year) 7.14% (43.04%) —
Revenue growth, 5-year CAGR (6.20%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVC BCTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 7.07 4.73
Net debt to EBITDA 0.21 0.66 0.96

Dividend

Metric ABVC BCTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABVC BCTX Biotechnology median
Market cap 33.96m 37.24m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack